Effectiveness of homologous and heterologous BNT162b2 and CoronaVac booster vaccination against severe COVID-19 outcomes

Effectiveness of homologous and heterologous BNT162b2 and CoronaVac booster vaccination against severe COVID-19 outcomes

Introduction: Evidence of the waning immunity of coronavirus disease 2019 (COVID-19) primary vaccination, and immune evasion by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has led to the rollout of booster vaccination in many countries. Assessing the effectiveness of b...

Full description

Saved in:
Bibliographic Details
Main Authors: Masliyana Husin, Peter Seah Keng Tok, Jing Lian Suah, Boon Hwa Tng, Thevesh Thevananthan, Kalaiarasu M Peariasamy, Sheamini Sivasampu
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2025-01-01
Series:Journal of Infection in Developing Countries
Subjects:
SARS-CoV-2
COVID-19
vaccines
BNT162b2
CoronaVac
booster
Online Access:https://jidc.org/index.php/journal/article/view/18946
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items